EQUR

E Qure (QB) Stock Price

0.075
0.00 (0.0%)
0.075
Best deals to access real time data!
Real-Time Alerts for Volume Breakouts, Highs and Lows for NYSE, NASDAQ, Amex, OTC Markets and OTCBB
Monthly Subscription
for only
$67.09
Canna Trader Pro
Monthly Subscription
for only
$59.99
Small Cap Basic
Monthly Subscription
for only
$33.03
VAT not included
Company Name Stock Ticker Symbol Market Type
E Qure Corporation (QB) EQUR OTCMarkets Common Stock
  Price Change Change Percent Stock Price Low Price High Price Open Price Close Price Last Traded
0.00 0.0% 0.075 0.00 0.00 0.00 0.075 08:00:00
Bid Price Ask Price Spread Spread % News
0.075 0.103 0.028 27.18% - -
Last Trade Time Type Quantity Stock Price Currency
- 0 $ 0.075 USD

E Qure (QB) Financials

Market Cap Shares in Issue Float Revenue Profit/Loss EPS PE Ratio
$ 2.59M 34.55M 13.48M $ - $ - - -
Short Interest Dividends Per Share Dividend Yield Ex-Div Date Insider B/S Insider % Owned
21.00 $ - 0.00% - -

more financials information »

E Qure (QB) News

Loading Messages....

{{bbMessage.M_Alias}} {{bbMessage.MSG_Date}} {{bbMessage.HowLongAgo}} {{bbMessage.MSG_ID}} {{bbMessage.MSG_Subject}}

Loading Messages....


No posts yet, be the first! No {{symbol}} Message Board. Create One! See More Posts on {{symbol}} Message Board See More Message Board Posts

Historical EQUR Price Data

Period † Open High Low VWAP Avg. Daily Vol Change %
1 Week0.000.000.000.0000.000.0%
1 Month0.1040.1040.0750.075700-0.029-27.88%
3 Months0.100.120.0410.09445976,414-0.025-25.0%
6 Months0.0990.160.030.07012529,079-0.024-24.24%
1 Year0.06050.160.030.066890813,6390.014523.97%
3 Years0.100.170.030.074743615,450-0.025-25.0%
5 Years0.510.510.030.113917514,619-0.435-85.29%

E Qure (QB) Description

E-Qure Corp. is engaged in the development and commercialization of its patented Bio-electrical Signal Therapy or BST Device, a new electrotherapy for the noninvasive treatment of hard to heal chronic wounds using electrical simulation to promote renewed blood flow and oxygen in order to induce local cell regeneration. The BST Device, designed to address limitations of competitors' wound care devices, is used to treat chronic wounds, primarily Stage III and Stage IV ulcers, and severe Stage II wounds. Our BST Device has received: (i) regulatory approval and CE certification permitting sale in the European Union markets; (ii) official certification from the Israeli Ministry of Health for use of the BST Device in Israel. The Company has entered into distribution agreements with third parties to market and sell its BST Device in several countries and is in the process of developing world-wide distribution arrangements. Company will launch a double arm, randomized clinical trial (RCT - Randomized Control Trial) in Israel to help promote the use of the BST device with local health care providers.


Your Recent History
USOTC
EQUR
E Qure (QB..
Register now to watch these stocks streaming on the ADVFN Monitor.

Monitor lets you view up to 110 of your favourite stocks at once and is completely free to use.